Ashley Mansell
Adiso Therapeutics, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
ADS032, the first dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of infectious and inflammatory diseases (#4)
2:50 PM
Ashley Mansell
Session 2: Innate Immunity
Activation of the NLRP3 inflammasome by Hendra Virus C-protein (#105)
8:00 PM
Kristian T Barry
Poster Session I
Gasdermin D deficiency limits the severity of pulmonary disease during influenza A virus infection (#189)
8:00 PM
Sarah Rosli
Poster Session I